glp-1 diarrhea Common Weight-loss Side Effects GLP-1 and Gut Health: Addressing

Description

Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, representing a distinct but related medication class

La pgina de inicio debe comunicar con precisin las promociones vigentes, los requisitos de apuesta y los lmites de pago

This can lead to increased drug exposure and heightened risk of adverse effects, particularly with narrow therapeutic index drugs like dabigatran [141]

Diabetes Res Clin Pract 222:112088 Paik JM, Tesfaye H, Curhan GC, Zakoul H, Wexler DJ, Patorno E (2024) Sodium-glucose cotransporter 2 inhibitors and nephrolithiasis risk in patients with type 2 diabetes